MMA 2019 Annual Conference Recording: The Dynamic Pharmaceutical Market: Future Drug Policy & Drug Prices
AMA PRA Category 1 CreditsTM are available! Click View More below for additional information.
this item can only be purchased by current members.
Would you like to...
Prescription drugs are often prescribed by doctors to address specific patient healthcare needs. While sitting in the doctor’s waiting room, the patient often will think about "Will the doctor prescribe a medication and how much will it cost me?" The cost of prescription drugs is at the top of the...
Prescription drugs are often prescribed by doctors to address specific patient healthcare needs. While sitting in the doctor’s waiting room, the patient often will think about "Will the doctor prescribe a medication and how much will it cost me?" The cost of prescription drugs is at the top of the public policy agenda and may affect the long-term viability of Medicare and Medicaid. Commercial health plans sponsored by employers and other private payers are concerned about the impact of drug prices on their total healthcare spending. At the same time, the news is full of stories that appear to be examples of price gouging on prescription drugs such as EpiPen, Insulin, HP Acthar, Daraprim, Colchrys, Glumetza, Zegerid, MS drugs, and others. Where are federal and state policy makers headed with drug pricing policy? What can you do for your patients with respect to getting needed medications at a reasonable cost?
Speaker: Stephen W. Schondelmeyer, PharmD, PhD, FAPhA, Director, PRIME Institute, University of Minnesota
Dr. Schondelmeyer has reported that he has no actual or potential conflicts of interest in relation to this activity. The MMA staff and other planning committee members who were involved in the development and implementation of this activity have no actual or potential conflicts of interest in relation to this activity. No commercial support was received for the development or implementation of this activity.
To receive CME credit for this activity, complete and submit the online evaluation form. Upon successful completion of the evaluation, you will be emailed a certificate of completion within 2 weeks. You may contact the accredited provider with questions regarding this program at firstname.lastname@example.org. Participants must complete all necessary activity components by the above ‘valid through’ date to be eligible to claim CME credit.
The Minnesota Medical Association (MMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Minnesota Medical Association designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.